M&A Transaction Database
Switzerland M&A Transactions
Mergers and acquisitions in the Switzerland country.
Never miss a transaction
Get instant notifications when new M&A transactions matching "Switzerland" are published.
Filters
5 shown
SERB Pharmaceuticals secures European and MENA rights for Hansa Biopharma's Idefirix® (imlifidase) in a €115M deal, enhancing kidney transplant options.
SERB Pharmaceuticals secures European and MENA rights for Hansa Biopharma's imlifidase, a key therapy for highly sensitized kidney transplant patients, in a €115M deal.
Private equity firms EQT and IDG Capital are in advanced talks to acquire Swiss peptide therapeutics manufacturer PolyPeptide, valued near $1.6 billion.
EQT AB and IDG Capital are shortlisted to acquire Swiss peptide drug manufacturer PolyPeptide Group, valued at $1.6 billion. Altaris also remains in talks.
GoMore acquires Getaround Europe, creating the continent's largest peer-to-peer carsharing service. Learn about market consolidation and growth strategies.
Never Miss a Deal
Get weekly investment intelligence. Free forever.
You reached the end (5 deals).